Download PDF
Semin intervent Radiol 2017; 34(02): 176-181
DOI: 10.1055/s-0037-1602592
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Decision Making in Interventional Oncology: Ablative Options in the Lung

Kyungmouk Steve Lee
1   Department of Radiology, Weill Cornell Medicine, New York
,
Joseph P. Erinjeri
2   Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
01 June 2017 (online)

Also available at
   Permissions and Reprints

Abstract

Image-guided ablation is safe and effective for the treatment of both primary and metastatic tumors in the lung. This article reviews the three most commonly used ablative options: radiofrequency ablation, microwave ablation, and cryoablation. We describe the advantages of each ablation modality in the lung and how to choose the most appropriate ablation device based on patient and tumor characteristics. The optimal technique for lung ablation is discussed and technical tips for improving clinical outcome are described.

Keywords

lung ablation - image-guided ablation - lung cancer - interventional radiology
 

  • References

  • 1 Brambilla E, Travis W. Lung cancer. In: Stewart BW, Wild CP. , eds. World Cancer Report. Lyon: World Health Organization; 2014
    Google Scholar
  • 2 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66 (01) 7-30
    CrossrefPubMedGoogle Scholar
  • 3 Kwan SW, Mortell KE, Talenfeld AD, Brunner MC. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer. J Vasc Interv Radiol 2014; 25 (01) 1-9.e1
    CrossrefPubMedGoogle Scholar
  • 4 Kwan SW, Mortell KE, Hippe DS, Brunner MC. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer. J Vasc Interv Radiol 2014; 25 (10) 1558-1564 , quiz 1565
    CrossrefPubMedGoogle Scholar
  • 5 Binkley MS, Trakul N, Jacobs LR. , et al. Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy. Int J Radiat Oncol Biol Phys 2015; 92 (05) 1044-1052
    CrossrefPubMedGoogle Scholar
  • 6 Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174 (01) 57-59
    CrossrefPubMedGoogle Scholar
  • 7 Boston Scientific RF 3000 radiofrequency ablation system. Available at: http://www.bostonscientific.com/templatedata/imports/collateral/Radiology/broc_rf3000_03_us.pdf . Accessed April 27, 2017
    PubMed
  • 8 StarBurst (RITA) radiofrequency ablation system. Available at: http://www.angiodynamics.com/products/what-is-rfa . Accessed April 27, 2017
    PubMed
  • 9 Cool-Tip Covidien radiofrequency ablation system. Available at: http://surgical.covidien.com/products/ablation-systems/cool-tip-rf-ablation-system-e-series . Accessed April 27, 2017
    PubMed
  • 10 Simon CJ, Dupuy DE, DiPetrillo TA. , et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243 (01) 268-275
    CrossrefPubMedGoogle Scholar
  • 11 Ambrogi MC, Fanucchi O, Cioni R. , et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol 2011; 6 (12) 2044-2051
    CrossrefPubMedGoogle Scholar
  • 12 Chua TC, Sarkar A, Saxena A, Glenn D, Zhao J, Morris DL. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol 2010; 21 (10) 2017-2022
    CrossrefPubMedGoogle Scholar
  • 13 Palussière J, Marcet B, Descat E. , et al. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol 2011; 34 (05) 989-997
    CrossrefPubMedGoogle Scholar
  • 14 de Baère T, Aupérin A, Deschamps F. , et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 2015; 26 (05) 987-991
    CrossrefPubMedGoogle Scholar
  • 15 Dupuy DE, Fernando HC, Hillman S. , et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer 2015; 121 (19) 3491-3498
    CrossrefPubMedGoogle Scholar
  • 16 Lencioni R, Crocetti L, Cioni R. , et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9 (07) 621-628
    CrossrefPubMedGoogle Scholar
  • 17 Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics 2005; 25 (Suppl. 01) S69-S83
    CrossrefPubMedGoogle Scholar
  • 18 Evident (Covidien) microwave ablation system. Available at: http://surgical.covidien.com/products/ablation-systems . Accessed April 27, 2017
    PubMed
  • 19 Microtherm X. . BSD microwave ablation system. Available at: http://www.bsdmedical.com/usa/brochures/Microthermx_Brochure.pdf . Accessed April 27, 2017
    PubMed
  • 20 Avecure Medwaves microwave ablation system. Available at: http://www.medwaves.com/ . Accessed April 27, 2017
    PubMed
  • 21 Certus 140 Neuwave Medical microwave ablation system. Available at: http://www.neuwavemedical.com/NeuWaveMedicalFilePile/NeuWaveFDAClearancePress20101028Final9.pdf . Accessed April 27, 2017
    PubMed
  • 22 AMICA microwave ablation system. Available at: http://www.amarantoweb.com/hsmedical/drive/File/AMICA_eng.pdf . Accessed April 27, 2017
    PubMed
  • 23 Acculis MTA microwave ablation system. Available at: http://www.angiodynamics.com/products/Acculis . Accessed April 27, 2017
    PubMed
  • 24 Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 2008; 247 (03) 871-879
    CrossrefPubMedGoogle Scholar
  • 25 Vogl TJ, Worst TS, Naguib NNN, Ackermann H, Gruber-Rouh T, Nour-Eldin N-EA. Factors influencing local tumor control in patients with neoplastic pulmonary nodules treated with microwave ablation: a risk-factor analysis. AJR Am J Roentgenol 2013; 200 (03) 665-672
    CrossrefPubMedGoogle Scholar
  • 26 Belfiore G, Ronza F, Belfiore MP. , et al. Patients' survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol 2013; 82 (01) 177-181
    CrossrefPubMedGoogle Scholar
  • 27 Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37 (03) 171-186
    CrossrefPubMedGoogle Scholar
  • 28 Izumi Y, Oyama T, Ikeda E, Kawamura M, Kobayashi K. The acute effects of transthoracic cryoablation on normal lung evaluated in a porcine model. Ann Thorac Surg 2005; 79 (01) 318-322 , discussion 322
    CrossrefPubMedGoogle Scholar
  • 29 Hinshaw JL, Littrup PJ, Durick N. , et al. Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol 2010; 33 (06) 1180-1185
    CrossrefPubMedGoogle Scholar
  • 30 Yamauchi Y, Izumi Y, Hashimoto K. , et al. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer. PLoS One 2012; 7 (03) e33223
    CrossrefPubMedGoogle Scholar
  • 31 Maiwand MO. The role of cryosurgery in palliation of tracheo-bronchial carcinoma. Eur J Cardiothorac Surg 1999; 15 (06) 764-768
    CrossrefPubMedGoogle Scholar
  • 32 Endocare cryotherapy system. Available at: https://www.healthtronics.com/physicians/cryotherapy/cryotherapy-services-and-solutions . Accessed April 27, 2017
    PubMed
  • 33 Cryohit cryotherapy system. Available at: http://www.galilmedical.com/ . Accessed April 27, 2017
    PubMed
  • 34 de Baere T, Tselikas L, Woodrum D. , et al. Evaluating cryoablation of metastatic lung tumors in patients--safety and efficacy: the ECLIPSE trial--interim analysis at 1 year. J Thorac Oncol 2015; 10 (10) 1468-1474
    CrossrefPubMedGoogle Scholar
  • 35 Yashiro H, Nakatsuka S, Inoue M. , et al. Factors affecting local progression after percutaneous cryoablation of lung tumors. J Vasc Interv Radiol 2013; 24 (06) 813-821
    CrossrefPubMedGoogle Scholar
  • 36 Moore W, Talati R, Bhattacharji P, Bilfinger T. Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol 2015; 26 (03) 312-319
    CrossrefPubMedGoogle Scholar
  • 37 Welch BT, Brinjikji W, Schmit GD. , et al. A national analysis of the complications, cost, and mortality of percutaneous lung ablation. J Vasc Interv Radiol 2015; 26 (06) 787-791
    CrossrefPubMedGoogle Scholar
  • 38 Hiraki T, Gobara H, Mimura H. , et al. Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases. J Vasc Interv Radiol 2010; 21 (07) 1129-1133
    CrossrefPubMedGoogle Scholar
  • 39 Matsui Y, Hiraki T, Gobara H. , et al. Phrenic nerve injury after radiofrequency ablation of lung tumors: retrospective evaluation of the incidence and risk factors. J Vasc Interv Radiol 2012; 23 (06) 780-785
    CrossrefPubMedGoogle Scholar
  • 40 Kashima M, Yamakado K, Takaki H. , et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences. AJR Am J Roentgenol 2011; 197 (04) W576-80
    PubMedGoogle Scholar
  • 41 Borghol S, Alberti N, Frulio N. , et al. Pulmonary artery pseudoaneurysm after radiofrequency ablation: report of two cases. Int J Hyperthermia 2015; 31 (01) 1-4
    CrossrefPubMedGoogle Scholar
  • 42 Vaughn C, Mychaskiw II G, Sewell P. Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. Anesth Analg 2002; 94 (05) 1149-1151
    CrossrefPubMedGoogle Scholar
  • 43 Nomura M, Yamakado K, Nomoto Y. , et al. Complications after lung radiofrequency ablation: risk factors for lung inflammation. Br J Radiol 2008; 81 (963) 244-249
    CrossrefPubMedGoogle Scholar
  • 44 Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 2010; 254 (01) 301-307
    CrossrefPubMedGoogle Scholar
  • 45 Durick NA, Laeseke PF, Broderick LS. , et al. Microwave ablation with triaxial antennas tuned for lung: results in an in vivo porcine model. Radiology 2008; 247 (01) 80-87
    CrossrefPubMedGoogle Scholar
  • 46 Lee KS, Takaki H, Yarmohammadi H. , et al. Pleural puncture that excludes the ablation zone decreases the risk of pneumothorax after percutaneous microwave ablation in porcine lung. J Vasc Interv Radiol 2015; 26 (07) 1052-1058
    CrossrefPubMedGoogle Scholar
  • 47 Sakurai J, Hiraki T, Mukai T. , et al. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol 2007; 18 (1, Pt 1): 141-145
    CrossrefPubMedGoogle Scholar
  • 48 Anai H, Uchida BT, Pavcnik D. , et al. Effects of blood flow and/or ventilation restriction on radiofrequency coagulation size in the lung: an experimental study in swine. Cardiovasc Intervent Radiol 2006; 29 (05) 838-845
    CrossrefPubMedGoogle Scholar
  • 49 Hinshaw JL, Sampson L, Lee Jr FTJ, Laeseke PF, Brace CL. Does selective intubation increase ablation zone size during pulmonary cryoablation?. J Vasc Interv Radiol 2008; 19 (10) 1497-1501
    CrossrefPubMedGoogle Scholar